HIMS stock tanking almost 10% on revenue miss.
Hims & Hers Health
HIMS
NYSE
IPO2021
about HIMS
Hims & Hers Health provides telehealth and digital health services, offering primary care, mental health, and other medical consultations through an accessible online platform.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $15.65 | $16.30 | $15.29 | $3.6B | 25.38M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.07 | 21.09 | 6.57 | 1.97% | 2.63% | 0% |
HIMS stock is taking a nose dive after Novo Nordisk announces its collaboration with Hims & Hers is being terminated. This is due to allegations that Hims & Hers failed to comply with laws prohibiting mass sales of compounded drugs, putting the public safety at risk.